Effects of ε4 on object recognition in the non-demented elderly

Current Aging Science

Volumn 3, Issue 2, 2010, Pages 127-137

  Haley, Gwendolen E ^a   Berteau Pavy, Frederique ^a   Parkv, Byung ^b   Raber, Jacob ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Aging; Apoe; Cortisol; Humans; Object recognition; Testosterone

Indexed keywords

APOLIPOPROTEIN E4; CORTISONE; TESTOSTERONE;

ADULT; AGE; AGED; ARTICLE; COGNITIVE DEFECT; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NEUROPSYCHOLOGICAL TEST; NORMAL HUMAN; NOVEL IMAGE NOVEL LOCATION OBJECT RECOGNITION TEST; PREDICTOR VARIABLE; PRIORITY JOURNAL; RECOGNITION; TASK PERFORMANCE; AGING; CHI SQUARE DISTRIBUTION; COGNITION; GENETICS; GENOTYPE; GERIATRIC ASSESSMENT; LONGITUDINAL STUDY; MEMORY; METABOLISM; MIDDLE AGED; PATIENT; PHENOTYPE; RISK ASSESSMENT; RISK FACTOR; SALIVA; STATISTICAL MODEL; TIME; UNITED STATES;

AGED; AGED, 80 AND OVER; AGING; APOLIPOPROTEIN E4; CHI-SQUARE DISTRIBUTION; COGNITION; CORTISONE; FEMALE; GENOTYPE; GERIATRIC ASSESSMENT; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OREGON; PATIENT DROPOUTS; PHENOTYPE; RECOGNITION (PSYCHOLOGY); RISK ASSESSMENT; RISK FACTORS; SALIVA; TESTOSTERONE; TIME FACTORS;

EID: 77953798688     PISSN: 18746098     EISSN: 18746128     Source Type: Journal    
DOI: 10.2174/1874609811003020127     Document Type: Article

References (75)

1. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988; 240: 622-30.
2. De Blasi S, Montesanto A, Martino C, Dato S, De Rango F, Bruni AC, et al. APOE polymorphism affects episodic memory among non demented elderly subjects. Exp Gerontol 2009; 44(3): 224-7.
3. Adamson MM, Landy KM, Duong S, Fox-Bosetti S, Ashford JW, Murphy GM, et al. Apolipoprotein E varepsilon4 influences on episodic recall and brain structures in aging pilots. Neurobiol Aging 2008;.[Epub ahead of print].
4. Reynolds CA, Prince JA, Feuk L, Brookes AJ, Gatz M, Pedersen NL. Longitudinal memory performance during normal aging: twin association models of APOE and other Alzheimer candidate genes. Behav Genet 2006; 36(2): 185-94.
5. de Frias CM, Bunce D, Wahlin A, Adolfsson R, Sleegers K, Cruts M, et al. Cholesterol and triglycerides moderate the effect of apolipoprotein E on memory functioning in older adults. J Gerontol B Psychol Sci Soc Sci 2007; 62(2): P112-8.
6. Berteau-Pavy F, Park B, Raber J. Effects of sex and APOE 4 on object recognition and spatial navigation in the elderly. Neuroscience 2007; 147: 6-17.
7. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997; 278(16): 1349-56.
8. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Roses AD, et al. The apolipoprotein E 4 allele and sex- specific risk of Alzheimer's disease. JAMA 1995; 273: 373-4.
9. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921-3.
10. Roses AD. Apolipoprotein E and Alzheimer's disease: a rapidly expanding field with medical and epidemiological consequences. Ann NY Acad Sci 1996; 802: 50-7.
11. Selkoe DK, Schenk D. Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. Ann Rev Pharmacol Toxicol 2003; 43: 545-84.
12. Adak S, Illouz K, Gorman W, Tandon R, Zimmerman EA, Guariglia R, et al. Predicting the rate of cognitive decline in aging and early Alzheimer disease. Neurology 2004; 63(1): 108-14.
13. Howieson DB, Camicioli R, Quinn J, Silbert LC, Care B, Moore MM, et al. Natural history of cognitive decline in the old old. Neurology 2003; 60(9): 1489-94.
14. Brayne C, Harrington CR, Wischik CM, Huppert FA, Chi LY, Xuereb JH, et al. Apolipoprotein E genotype in the prediction of cognitive decline and dementia in a prospectively studied elderly population. Dementia 1996; 7(3): 169-74.
15. Bennett DA, Schneider JA, Wilson RS, Bienias JL, Berry-Kravis E, Arnold SE. Amyloid mediates the association of apolipoprotein E e4 allele to cognitive function in older people. J Neurol Neurosurg Psychiatry 2005; 76(9): 1194-9.
16. Bennett DA, Wilson RS, Schneider JA, Evans DA, Aggarwal NT, Arnold SE, et al. Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease. Neurology 2003; 60(2): 246-52.
17. Wilson RS, Schneider JA, Barnes LL, Beckett LA, Aggarwal NT, Cochran EJ, et al. The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period. Arch Neurol 2002; 59(7): 1154-60.
18. Aggarwal NT, Wilson RS, Beck TL, Bienias JL, Berry-Kravis E, Bennett DA. The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment. Neurocase 2005; 11(1): 3-7.
19. Lahiri DK, Sambamurti K, Bennett DA. Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer's disease. Neurobiol Aging 2004; 25(5): 651-60.
20. Bondi M, Salmon DP, Monsch AU, Galasko D, Butters N, Klauber MR, et al. Episodic memory changes are associated with the APOE- 4 allele in nondemented older adults. Neurology 1995; 45(12): 2203-6.
21. Storandt M, Botwick J, Danzinger W, Berg L, Hughes C. Psychometric differentiation of mild senile demintia of the Azheimer type. Arch Neurol 1984; 41: 497-9.
22. Eslinger P, Damasio A, Benton A, Van Allen M. Neuropsy- chological detection of abnormal mental decline in older persons. JAMA 1985; 253: 670-4.
23. Knopman D, Ryberg S. A verbal memory test with high predictive accuracy for dementia of the Alzheimer type. Arch Neurol 1989; 46: 141-5.
24. Fuld P, Masur D, Blau A, Crystal H, Aronson M. Object-memory evaluation for prospective detection of dementia in normal functioning elderly: predictive and normative data. J Clin Exp Neuropsychol 1990; 12: 520-8.
25. Flicker C, Ferris SH, Reisberg B. Mild cognitive impairment in the elderly. Predictors of dementia. Neurology 1991; 41: 1006-9.
26. Welsh K, Butters N, Hughes J, Mohs R, Heyman A. Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Arch Neurol 1991; 48: 278-81.
27. Petersen R, Smith G, Ivnik R, Kokmen E, Tangalos E. Memory function in very early Alzheimer's disease. Neurology 1994; 44: 867-72.
28. Jacobs D, Sano M, Dooneief G, Marder K, Bell K, Stern Y. Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology 1995; 45: 957-62.
29. Caselli R, Graff-Radford N, Reiman E, Weaver A, Osborne D, Lucas J, et al. Preclinical memory decline in cognitive normal apolipoprotein E-epsilon 4 homozygotes. Neurology 1999; 53: 201-7.
30. Fox N, Warrington E, Seiffer A, Agnew S, Rossor M. Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease. A longitudinal prospective study. Brain 1998; 121: 1631-9.
31. Tierney M, Szalai J, Snow W, Fisher R, Nores A, Nadon G, et al. Prediction of probable Alzheimer's disease in memory impaired patients: a prospective longitudinal study. Neurology 1996; 46: 661-5.
32. Dere E, Kart-Teke E, Huston JP, De Souza Silva MA. The case for episodic memory in animals. Neurosci Biobehav Rev 2006; 30(8): 1206-24.
33. Benice TS, Rizk A, Kohama S, Pfankuch T, Raber J. Sex- differences in age-related cognitive decline in C57BL/6J mice associated with increased brain microtubule-associated protein 2 and synaptophysin immunoreactivity. Neuroscience 2006; 137(2): 413-23.
34. Pfankuch T, Rizk A, Olsen R, Poage C, Raber J. Role of circulating androgen levels in effects of apoE4 on cognitive function. Brain Res 2005; 1053: 88-96.
35. Raber J, Bongers G, LeFevour A, Buttini M, Mucke L. Androgens protect against apolipoprotein E4-induced cognitive deficits. J Neurosci 2002; 22: 5204-9.
36. Rizk-Jackson A, Acevedo S, Inman D, Howieson D, Benice T, Raber J. Effects of sex on object recognition and spatial navigation in humans. Behav Brain Res 2006; 173: 181-90.
37. Magri F, Cravello L, Barili L, Sarra S, Cinchetti W, Salmoiraghi F, et al. Stress and dementia: the role of the hypothalamicpituitary- adrenal axis. Aging Clin Exp Res 2006; 18(2): 167-70.
38. MacLullich AM, Deary IJ, Starr JM, Ferguson KJ, Wardlaw JM, Seckl JR. Plasma cortisol levels, brain volumes and cognition in healthy elderly men. Psychoneuroendocrinology 2005; 30(5): 505-15.
39. Li G, Cherrier MM, Tsuang DW, Petrie EC, Colasurdo EA, Craft S, et al. Salivary cortisol and memory function in human aging. Neurobiol Aging 2006; 27(11): 1705-14.
40. Lupien SJ, Fiocco A, Wan N, Maheu F, Lord C, Schramek T, et al. Stress hormones and human memory function across the lifespan. Psychoneuroendocrinology 2005; 30(3): 225-42.
41. Lupien SJ, de Leon M, de Santi S, Convit A, Tarshish C, Nair NP, et al. Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci 1998; 1(1): 69-73.
42. Aisa B, Tordera R, Lasheras B, Del Rio J, Ramirez MJ. Cognitive impairment associated to HPA axis hyperactivity after maternal separation in rats. Psychoneuroendocrinology 2007; 32(3): 256-66.
43. Sapolsky R. Stress, the aging brain, and the mechanisms of neuron death. Cambridge: MIT Press 1992.
44. Konrad C, Engelien A, Schoning S, Zwitserlood P, Jansen A, Pletziger E, et al. The functional anatomy of semantic retrieval is influenced by gender, menstrual cycle, and sex hormones. J Neural Transm 2008; 115(9): 1327-37.
45. Yaffe K, Lui LY, Zmuda J, Cauley J. Sex hormones and cognitive function in older men. J Am Geriatr Soc 2002; 50(4): 707-12.
46. Barrett-Connor E, Goodman-Gruen D, Patay B. Endogenous sex hormones and cognitive function in older men. J Clin Endocrinol Metab 1999; 84(10): 3681-5.
47. Janowsky JS, Chavez B, Orwoll E. Sex steroids modify working memory. J Cogn Neurosci 2000; 12(3): 407-14.
48. Janowsky JS, Oviatt SK, Orwoll ES. Testosterone influences spatial cognition in older men. Behav Neurosci 1994; 108(2): 325-32.
49. Cherrier MM, Asthana S, Plymate S, Baker L, Matsumoto AM, Peskind E, et al. Testosterone supplementation improves spatial and verbal memory in healthy older men. Neurology 2001; 57(1): 80-8.
50. Cherrier MM, Matsumoto AM, Amory JK, Ahmed S, Bremner W, Peskind ER, et al. The role of aromatization in testosterone supplementation: effects on cognition in older men. Neurology 2005; 64(2): 290-6.
51. Acevedo SF, Tittle S, Raber J. Transgenic expression of androgen receptors improves spatial memory retention in both sham- irradiated and 137Cs gamma-irradiated female mice. Radiat Res 2008; 170(5): 572-8.
52. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
53. Wechsler D. WMS-III administration and scoring manual. San Antonio, TX: Psychological Corporation 1997.
54. Beck AT, Epstein N, Brown G, Steer RA. An inventroy for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988; 65: 893-7.
55. Jastak S, Wilkinson G. The wide range achievement test, revised. Wilmington, DE: Jastak Associates 1994.
56. Wood AM, White IR, Hillsdon M, Carpenter J. Comparison of imputation and modelling methods in the analysis of a physical activity trial with missing outcomes. Int J Epidemiol 2005; 34(1): 89-99.
57. Caselli RJ, Dueck AC, Osborne D, Sabbagh MN, Connor DJ, Ahern GL, et al. Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect. N Engl J Med 2009; 361(3): 255-63.
58. Baxter LC, Caselli RJ, Johnson SC, Reiman E, Osborne D. Apolipoprotein E epsilon 4 affects new learning in cognitively normal individuals at risk for Alzheimer's disease. Neurobiol Aging 2003; 24(7): 947-52.
59. Caselli RJ, Reiman EM, Osborne D, Hentz JG, Baxter LC, Hernandez JL, et al. Longitudinal changes in cognition and beha- vior in asymptomatic carriers of the APOE e4 allele. Neurology 2004; 62(11): 1990-5.
60. Caselli RJ, Chen K, Lee W, Alexander GE, Reiman EM. Correlating cerebral hypometabolism with future memory decline in subsequent converters to amnestic pre-mild cognitive impairment. Arch Neurol 2008; 65(9): 1231-6.
61. Welsh-Bohmer KA, Ostbye T, Sanders L, Pieper CF, Hayden KM, Tschanz JT, et al. Neuropsychological performance in advanced age: influences of demographic factors and Apolipoprotein E: findings from the Cache County Memory Study. Clin Neuropsychol 2009; 23(1): 77-99.
62. Luciano M, Gow AJ, Taylor MD, Hayward C, Harris SE, Campbell H, et al. Apolipoprotein E is not related to memory abilities at 70 years of age. Behav Genet 2009; 39(1): 6-14.
63. Muller M, Schupf N, Manly JJ, Mayeux R, Luchsinger JA. Sex hormone binding globulin and incident Alzheimer's disease in elderly men and women. Neurobiol Aging 2008; [Epub ahead of print].
64. Hogervorst E, Bandelow S, Combrinck M, Smith AD. Low free testosterone is an independent risk factor for Alzheimer's disease. Exp Gerontol 2004; 39(11-12): 1633-9.
65. Hogervorst E, Combrinck M, Smith AD. Testosterone and gonadotropin levels in men with dementia. Neuro Endocrinol Lett 2003; 24(3-4): 203-8.
66. Viega S, Melcangi RC, Doncarlos LL, Garcia-Segura LM, Azcoitia I. Sex hormones and brain aging. Exp Gerontol 2004; 39: 1623-31.
67. Yeap BB. Testosterone and ill-health in aging men. Nat Clin Pract Endocrinol Metab 2009; 5(2): 113-21.
68. Brown M. Skeletal muscle and bone: effect of sex steroids and aging. Adv Physiol Educ 2008; 32(2): 120-6.
69. Scuteri A, Najjar SS, Muller D, Andres R, Morrell CH, Zonderman AB, et al. ApoE4 allele and the natural history of cardiovascular risk factors. Am J Physiol Endocrinol Metab 2005; 289(2): E322-7.
70. Dick IM, Devine A, Marangou A, Dhaliwal SS, Laws S, Martins RN, et al. Apolipoprotein E4 is associated with reduced calcaneal quantitative ultrasound measurements and bone mineral density in elderly women. Bone 2002; 31(4): 497-502.
71. Eggertsen G, Heimburger O, Stenvinkel P, Berglund L. Influence of variation at the apolipoprotein E locus on lipid and lipoprotein levels in CAPD patients. Nephrol Dial Transplant 1997; 12(1): 141-4.
72. Eggertsen G, Tegelman R, Ericsson S, Angelin B, Berglund L. Apolipoprotein E polymorphism in a healthy Swedish population: variation of allele frequency with age and relation to serum lipid concentrations. Clin Chem 1993; 39(10): 2125-9.
73. van der Vlies AE, Koedam EL, Pijnenburg YA, Twisk JW, Scheltens P, van der Flier WM. Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset. Psychol Med 2009: 1-5.
74. Sluimer JD, van der Flier WM, Karas GB, Fox NC, Scheltens P, Barkhof F, et al. Whole-brain atrophy rate and cognitive decline: longitudinal MR study of memory clinic patients. Radiology 2008; 248(2): 590-8.
75. Sluimer JD, Vrenken H, Blankenstein MA, Fox NC, Scheltens P, Barkhof F, et al. Whole-brain atrophy rate in Alzheimer disease: identifying fast progressors. Neurology 2008; 70(19 Pt 2): 1836-41.